This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

WILLARD OWEN THOMPSON, M.D.; PHEBE K. THOMPSON, M.D.; ALLEN G. BRAILEY, M.D.; ARCHIBALD C. COHEN, A.B.

Arch Intern Med. 1930;45(4):481-502.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The value of a short intensive course of iodine medication as a method of preparing a patient with exophthalmic goiter for thyroidectomy has been unquestioned since the report of Plummer¹ in 1923. Following his announcement, the use of iodine in this disease rapidly became widespread. It was soon noted by various observers, beginning with Starr, Segall and Means,² that in cases in which this medication was prolonged, its effect, though striking, was usually only temporary; and that after a few weeks the patient might be as ill as before it was started, if not worse. Thus, in general, the prolonged treatment for exophthalmic goiter with iodine alone has come to be regarded as a futile, if not a dangerous, procedure.

There are, however, some observations in the literature concerning favorable results in exophthalmic goiter with this method of treatment. Trousseau,³ in 1863, mentioned a patient in whom the disease was . . . [Full Text PDF of this Article]

Author Affiliations
Henry P. Walcott Fellow in Clinical Medicine, Harvard Medical School

BOSTON

From the Thyroid Clinic and Metabolism Laboratory, Massachusetts General Hospital.

Footnotes
Submitted for publication, Sept. 25, 1929.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?